Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 3
2(50.0%)
4Total
N/A(2)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06737237Not ApplicableEnrolling By Invitation

Cervical Plexus Versus Infiltration for Clavicular Operations (CERPICO)

Role: lead

NCT06990308Not ApplicableEnrolling By Invitation

Deflated and Inflated Cuff Endotracheal Extubations

Role: lead

NCT05598723Phase 3Recruiting

BOTOX® vs. XEOMIN® for Chronic Migraine

Role: lead

NCT04260607Phase 3Terminated

Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department

Role: lead

All 4 trials loaded